{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:19:44Z","timestamp":1785151184004,"version":"3.55.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T00:00:00Z","timestamp":1665964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Pulmonary large cell neuroendocrine carcinoma (LCNEC) is a rapidly progressive and easily metastatic high-grade lung cancer, with a poor prognosis when distant metastasis (DM) occurs. The aim of our study was to explore risk factors associated with DM in LCNEC patients and to perform survival analysis and to develop a novel nomogram-based predictive model for screening risk populations in clinical practice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The study cohort was derived from the Surveillance, Epidemiology, and End Results database, from which we selected patients with LCNEC between 2004 to 2015 and formed a diagnostic cohort (n = 959) and a prognostic cohort (n = 272). The risk and prognostic factors of DM were screened by univariate and multivariate analyses using logistic and Cox regressions, respectively. Then, we established diagnostic and prognostic nomograms using the data in the training group and validated the accuracy of the nomograms in the validation group. The diagnostic nomogram was evaluated using receiver operating characteristic curves, decision curve analysis curves, and the GiViTI calibration belt. The prognostic nomogram was evaluated using receiver operating characteristic curves, the concordance index, the calibration curve, and decision curve analysis curves. In addition, high- and low-risk groups were classified according to the prognostic monogram formula, and Kaplan\u2013Meier survival analysis was performed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In the diagnostic cohort, LCNEC close to bronchus, with higher tumor size, and with higher N stage indicated higher likelihood of DM. In the prognostic cohort (patients with LCNEC and DM), men with higher N stage, no surgery, and no chemotherapy had poorer overall survival. Patients in the high-risk group had significantly lower median overall survival than the low-risk group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Two novel established nomograms performed well in predicting DM in patients with LCNEC and in evaluating their prognosis. These nomograms could be used in clinical practice for screening of risk populations and treatment planning.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.973091","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T06:44:31Z","timestamp":1665989071000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Risk factors, survival analysis, and nomograms for distant metastasis in patients with primary pulmonary large cell neuroendocrine carcinoma: A population-based study"],"prefix":"10.3389","volume":"13","author":[{"given":"Zhuo","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199106000-00003","article-title":"Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. an ultrastructural, immunohistochemical, and flow cytometric study of 35 cases","volume":"15","author":"Travis","year":"1991","journal-title":"Am J Surg Pathol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41379-021-00943-2","article-title":"Lung neuroendocrine neoplasms: recent progress and persistent challenges","volume":"35","author":"Rekhtman","year":"2022","journal-title":"Modern Pathol Off J US Can Acad Pathol Inc"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.664397","article-title":"Molecular characterization and prognostication of large cell neuroendocrine carcinoma and large cell carcinoma","volume":"11","author":"Chen","year":"2022","journal-title":"Front Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"E99","DOI":"10.1016\/j.cllc.2019.07.011","article-title":"Large-Cell neuroendocrine carcinoma of the lung: A population-based study","volume":"21","author":"Kinslow","year":"2020","journal-title":"Clin Lung Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.3390\/jcm11051461","article-title":"Large Cell neuroendocrine carcinoma of the lung: Current understanding and challenges","volume":"11","author":"Andrini","year":"2022","journal-title":"J Clin Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.05.020","article-title":"Clinical-pathologic challenges in the classification of pulmonary neuroendocrine neoplasms and targets on the horizon for future clinical practice","volume":"16","author":"Derks","year":"2021","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.7150\/jca.33367","article-title":"Comparative study of large cell neuroendocrine carcinoma and small cell lung carcinoma in high-grade neuroendocrine tumors of the lung: a large population-based study","volume":"10","author":"Wang","year":"2019","journal-title":"J Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2188","article-title":"The demographic and treatment options for patients with large cell neuroendocrine carcinoma of the lung","volume":"8","author":"Gu","year":"2019","journal-title":"Cancer Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"E6539","DOI":"10.7717\/peerj.6539","article-title":"Clinicopathological characteristics, treatment and survival of pulmonary large cell neuroendocrine carcinoma: A seer population-based study","volume":"7","author":"Cao","year":"2019","journal-title":"PEERJ"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.914541","article-title":"Lung large cell neuroendocrine carcinoma: an analysis of patients from the surveillance, epidemiology, and end-results (seer) database","volume":"25","author":"Deng","year":"2019","journal-title":"Med Sci Monitor Int Med J Exp Clin Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-20-780","article-title":"Development and validation of a nomogram for predicting the overall survival of patients with lung large cell neuroendocrine carcinoma","volume":"9","author":"Xi","year":"2020","journal-title":"Trans Cancer Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2147\/ijgm.s335040","article-title":"A clinical nomogram for predicting cancer-specific survival in pulmonary large-cell neuroendocrine carcinoma patients: A population-based study","volume":"14","author":"Ma","year":"2021","journal-title":"Int J Of Gen Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)71116-7","article-title":"Nomograms in oncology: More than meets the eye","volume":"16","author":"Balachandran","year":"2015","journal-title":"Lancet Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2007.12.9791","article-title":"How to build and interpret a nomogram for cancer prognosis","volume":"26","author":"Iasonos","year":"2008","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.672024","article-title":"Risk factors, prognostic factors, and nomograms for distant metastasis in patients with newly diagnosed osteosarcoma: a population-based study","volume":"12","author":"Chen","year":"2021","journal-title":"Front Endocrinol"},{"key":"B16","unstructured":"Surveillance, epidemiology, and end results (seer) program. seer*stat software version 8.3.9.2"},{"key":"B17","volume-title":"R: A language and environment for statistical computing. r foundation for statistical computing","year":"2022"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6744","article-title":"A new test and graphical tool to assess the goodness of fit of logistic regression models","volume":"35","author":"Nattino","year":"2016","journal-title":"Stat Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/jto.0000000000000589","article-title":"Pulmonary large-cell neuroendocrine carcinoma: From epidemiology to therapy","volume":"10","author":"Fasano","year":"2015","journal-title":"J Thorac Oncol Off Publ Int Assoc For Study Of Lung Cancer"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.3390\/cancers13081753","article-title":"Incidence and survival outcomes in patients with lung neuroendocrine neoplasms in the United States","volume":"13","author":"Shah","year":"2021","journal-title":"Cancers"},{"key":"B21","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3390\/medicina57020118","article-title":"Outcomes of patients with pulmonary large cell neuroendocrine carcinoma in i-iv stage","volume":"57","author":"Lowczak","year":"2021","journal-title":"Medicina (Kaunas Lithuania)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.6824","article-title":"Clinicopathological characteristics and prognosis of pulmonary large cell neuroendocrine carcinoma aged \u226565 years","volume":"7","author":"Cao","year":"2019","journal-title":"PEERJ"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1038\/s41467-018-03099-x","article-title":"Integrative genomic profiling of Large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors","volume":"9","author":"George","year":"2018","journal-title":"Nat Commun"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-15-2946","article-title":"Next-generation sequencing of pulmonary large cell neuroendocrine carcinoma reveals small cell carcinoma-like and non-small cell carcinoma-like subsets","volume":"22","author":"Rekhtman","year":"2016","journal-title":"Clin Cancer Res an Off J Am Assoc Cancer Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2018.02.002","article-title":"New insights into the molecular characteristics of pulmonary carcinoids and large cell neuroendocrine carcinomas, and the impact on their clinical management","volume":"13","author":"Derks","year":"2018","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2017.05.008","article-title":"Gene expression profiling of large cell lung cancer links transcriptional phenotypes to the new histological who 2015 classification","volume":"12","author":"Karlsson","year":"2017","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1177\/15353702211019697","article-title":"Role of sex hormones in lung cancer","volume":"246","author":"Fuentes","year":"2021","journal-title":"Exp Biol Med (Maywood NJ)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2022.01.016","article-title":"Evaluating prognostic factors for sex differences in lung cancer survival: findings from a large australian cohort","volume":"17","author":"Yu","year":"2022","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Of Lung Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1159\/000508376","article-title":"Ki-67 index of 55% distinguishes two groups of bronchopulmonary pure and composite large cell neuroendocrine carcinomas with distinct prognosis","volume":"111","author":"Milione","year":"2021","journal-title":"Neuroendocrinology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.3390\/cancers13061247","article-title":"Neuroendocrine carcinomas with atypical proliferation index and clinical behavior: A systematic review","volume":"13","author":"Feola","year":"2021","journal-title":"Cancers"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1530\/ec-19-0372","article-title":"Large Cell neuroendocrine carcinoma with a solitary brain metastasis and low ki-67: a unique subtype","volume":"8","author":"Hermans","year":"2019","journal-title":"Endocrine Connections"},{"key":"B32","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/his.14277","article-title":"Challenges in ki-67 assessments in pulmonary large-cell neuroendocrine carcinomas","volume":"78","author":"Walts","year":"2021","journal-title":"Histopathology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3390\/jcm9051370","article-title":"Outcomes of patients with clinical stage i-iiia large-cell neuroendocrine lung cancer treated with resection","volume":"9","author":"Lowczak","year":"2020","journal-title":"J Clin Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/ejcts\/ezu404","article-title":"Clinical management of atypical carcinoid and large-cell neuroendocrine carcinoma: a multicentre study on behalf of the european association of thoracic surgeons (ests) neuroendocrine tumours of the lung working group\u2020","volume":"48","author":"Filosso","year":"2015","journal-title":"Eur J Cardio-Thoracic Surg Off J Eur Assoc Cardio-Thoracic Surg"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.673901","article-title":"Comprehensive dissection of treatment patterns and outcome for patients with metastatic Large-cell neuroendocrine lung carcinoma","volume":"11","author":"Fisch","year":"2021","journal-title":"Front Oncol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1158\/1078-0432.CCR-19-0556","article-title":"The prognostic and therapeutic role of genomic subtyping by sequencing tumor or cell-free dna in pulmonary large-cell neuroendocrine carcinoma","volume":"26","author":"Zhuo","year":"2020","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1158\/1078-0432.CCR-17-1921","article-title":"Molecular subtypes of pulmonary large-cell neuroendocrine carcinoma predict chemotherapy treatment outcome","volume":"24","author":"Derks","year":"2018","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2021.04.030","article-title":"Prognostic factors of metastatic neuroendocrine carcinoma under first-line treatment with platinum etoposide with a focus on nec score and rb expression: results from the multicentre rbnec study of the groupe d\u2019etude des tumeurs endocrines (gte) and the endocan-renaten network","volume":"152","author":"Hadoux","year":"2021","journal-title":"Eur J Cancer (Oxford Engl 1990)"},{"key":"B39","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1093\/jrr\/rraa036","article-title":"The role of radiotherapy in pulmonary large cell neuroendocrine carcinoma: propensity score matching analysis","volume":"61","author":"Cao","year":"2020","journal-title":"J Radiat Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.7150\/jca.32446","article-title":"Double-edged role of radiotherapy in patients with pulmonary Large-cell neuroendocrine carcinoma","volume":"10","author":"Jiang","year":"2019","journal-title":"J Cancer"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.canrad.2020.02.004","article-title":"The role of postoperative radiotherapy (port) in pulmonary large cell neuroendocrine carcinoma (plcnec)","volume":"24","author":"Gang","year":"2020","journal-title":"Cancer Radiotherapie J la Societe Francaise Radiotherapie Oncologique"},{"key":"B42","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3390\/cancers14010177","article-title":"The role of conventionally fractionated radiotherapy and stereotactic radiotherapy in the treatment of carcinoid tumors and large-cell neuroendocrine cancer of the lung","volume":"14","author":"Bilski","year":"2022","journal-title":"Cancers"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00618-2015","article-title":"Clinical features of large cell neuroendocrine carcinoma: a population-based overview","volume":"47","author":"Derks","year":"2016","journal-title":"Eur Respir J"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.12993","article-title":"Clinicopathological characteristics and prognostic factors of pulmonary large cell neuroendocrine carcinoma: a large population-based analysis","volume":"10","author":"Yang","year":"2019","journal-title":"Thorac Cancer"},{"key":"B45","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1080\/0284186x.2018.1564841","article-title":"Management of brain metastases from large cell neuroendocrine carcinoma of the lung: improved outcomes with radiosurgery","volume":"58","author":"Wegner","year":"2019","journal-title":"Acta Oncol (Stockholm Sweden)"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2020.09.021","article-title":"Results of surgical resection of locally advanced pulmonary neuroendocrine tumors","volume":"112","author":"Girelli","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2018.01.008","article-title":"Association of pd-l1 expression with tumor-infiltrating immune cells and mutation burden in high-grade neuroendocrine carcinoma of the lung","volume":"13","author":"Kim","year":"2018","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1080\/07357907.2021.1988962","article-title":"Platinum doublet plus atezolizumab as first-line treatment in metastatic large cell neuroendocrine carcinoma: A single institution experience","volume":"40","author":"Vrontis","year":"2022","journal-title":"Cancer Invest"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.973091\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T11:32:05Z","timestamp":1666092725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.973091\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,17]]},"references-count":48,"alternative-id":["10.3389\/fendo.2022.973091"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.973091","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,17]]},"article-number":"973091"}}